The treatment of psoriasis with methotrexate.
D000293:Adolescent; D000328:Adult; D000368:Aged; D000469:Alkaline Phosphatase / Q000378:metabolism; D000505:Alopecia / Q000139:chemically induced; D000748:Anemia, Macrocytic / Q000139:chemically induced; D001219:Aspartate Aminotransferases / Q000378:metabolism; D003967:Diarrhea / Q000139:chemically induced; D004415:Dyspepsia / Q000139:chemically induced; D005260:Female; D006801:Humans; D008099:Liver / Q000503:physiopathology; D008111:Liver Function Tests; D008297:Male; D008727:Methotrexate / Q000009:adverse effects* / Q000627:therapeutic use*; D008875:Middle Aged; D009708:Nucleotidases / Q000378:metabolism; D011565:Psoriasis / Q000188:drug therapy*; D013280:Stomatitis / Q000139:chemically induced; D013448:Sulfobromophthalein / Q000378:metabolism
D013448:Sulfobromophthalein; D001219:Aspartate Aminotransferases; D009708:Nucleotidases; D000469:Alkaline Phosphatase; D008727:Methotrexate